About Us
MyoTherapeutics is a biotherapeutics company with a passion for improving mobility and quality of life in neuromuscular disease patients.  By focusing on innovative approaches to diagnosing, monitoring and treating cellular and molecular defects in skeletal muscle, we hope to accelerate the process of bringing new therapies to market and life-enhancing treatments to patients. 

Our Therapeutics Division  is focused on novel biotherapeutics in pre-clinical and early phase clinical trials for Amyotrophic Lateral Sclerosis (ALS) and Duchenne Muscular Dystrophy (DMD).  

Our Diagnostics Division is developing a panel of clinical assays that can be used in diagnosis and monitoring patients progression and response to treatment for ALS, DMD and other neuromuscular diseases.

Research & Development for Muscle-Based Diseases